|
Journal of Lipid Research, Vol. 43, 646-653, April 2002
Copyright © 2002 by Lipid Research, Inc.
Very long chain n-3 and n-6 polyunsaturated fatty acids bind strongly to liver fatty acid-binding protein
Andrew W. Norrisa and
Arthur A. Spectorb
a Department of Pediatrics, University of Iowa College of Medicine, Iowa City, IA 52242
b Department of Biochemistry, University of Iowa College of Medicine, Iowa City, IA 52242
Correspondence to:
Andrew W. Norris, at Joslin Diabetes Center, Cellular and Molecular Physiology, One Joslin Place, Boston, MA 02215., andrew.norris{at}joslin.harvard.edu (E-mail)
Synthesis of n-3 and n-6 very long chain-PUFAs (VLC-PUFAs) from 18-carbon essential fatty acids is differentially regulated. The predominant product arising from n-3 fatty acids is docosahexaenoic acid (22:6n-3), with the liver serving as the main site of production. The synthetic pathway requires movement of a 24-carbon intermediate from the endoplasmic reticulum to peroxisomes for retroconversion to 22:6n-3. The mechanism of this intra-organelle flux is unknown, but could be binding-protein facilitated. We thus investigated binding of a series of previously untested VLC-PUFAs to liver fatty acid-binding protein (L-FABP). Three fluorometric assays were employed, all of which showed strong binding (Kd' 10-8 to 10-7 M) of 20-, 22-, and 24-carbon n-3 PUFAs to L-FABP. In contrast, synthesis of the predominant n-6 PUFA product, arachidonic acid, does not require intra-organelle transport. However, we found that n-6 VLC-PUFAs bound to L-FABP with affinities (Kd' 10-8 to 10-7 M) comparable to their n-3 counterparts.
Although these results raise the possibility that L-FABP may participate in the cytoplasmic processing of n-3 and n-6 VLC-PUFAs, there is no evidence on the basis of binding affinities that L-FABP accounts for differences in the predominant products formed by the n-3 and n-6 PUFA metabolic pathways.Norris, A. W., and A. A. Spector. Very long chain n-3 and n-6 polyunsaturated fatty acids bind strongly to liver fatty acid-binding protein. J. Lipid Res. 2002. 43: 646653.
Supplementary key words:
24-carbon polyunsaturated fatty acids, docosahexaenoic acid, arachidonic acid, fatty acid binding assay

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Yan, Y. Gong, Y.-M. She, G. Wang, M. S. Roberts, and F. J. Burczynski
Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity
J. Lipid Res.,
December 1, 2009;
50(12):
2445 - 2454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Martin, B. P. Atshaves, H. Huang, A. L. McIntosh, B. J. Williams, P.-J. Pai, D. H. Russell, A. B. Kier, and F. Schroeder
Hepatic phenotype of liver fatty acid binding protein gene-ablated mice
Am J Physiol Gastrointest Liver Physiol,
December 1, 2009;
297(6):
G1053 - G1065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rowland, K. M. Knights, P. I. Mackenzie, and J. O. Miners
Characterization of the Binding of Drugs to Human Intestinal Fatty Acid Binding Protein (IFABP): Potential Role of IFABP as an Alternative to Albumin for in Vitro-in Vivo Extrapolation of Drug Kinetic Parameters
Drug Metab. Dispos.,
July 1, 2009;
37(7):
1395 - 1403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Newberry, Y. Xie, S. Kennedy, X. Han, K. K. Buhman, J. Luo, R. W. Gross, and N. O. Davidson
Decreased Hepatic Triglyceride Accumulation and Altered Fatty Acid Uptake in Mice with Deletion of the Liver Fatty Acid-binding Protein Gene
J. Biol. Chem.,
December 19, 2003;
278(51):
51664 - 51672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pawar and D. B. Jump
Unsaturated Fatty Acid Regulation of Peroxisome Proliferator-activated Receptor {alpha} Activity in Rat Primary Hepatoctes
J. Biol. Chem.,
September 19, 2003;
278(38):
35931 - 35939.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|